Press release
Antibody‐Drug Conjugates Market to Reach USD 57.02 Billion by 2030, Fueled by Rapid Oncology Advances and Contract Manufacturing Expansion
Antibody?Drug Conjugates Market Size & Trends | Mordor Intelligence
The global antibody‐drug conjugates (ADC) market is forecast to expand from USD 15.61 billion in 2025 to USD 57.02 billion by 2030, at a compound annual growth rate (CAGR) of 29.57% during the forecast period.
This sharp growth reflects wider adoption of ADC therapies in cancer care, ongoing approvals for novel treatments, and greater investment in precision oncology. ADCs combine monoclonal antibodies with potent cytotoxic agents, offering targeted cell killing that limits systemic toxicity. This precision makes them an increasingly attractive alternative to traditional chemotherapy.
Report Overview: https://www.mordorintelligence.com/industry-reports/antibody-drug-conjugates-market?utm_source=openpr
Key Trends
1. Surge in Precision Oncology Adoption
ADC therapies are increasingly replacing blunt chemotherapy by delivering drugs directly to cancer cells. High-profile launches such as Enhertu and Kadcyla, along with others in late-stage pipelines, underscore a broader industry shift toward safer, more effective cancer treatments.
2. Focus on Linker Technology
Technologies like cleavable linkers are playing a crucial role in ADC efficacy. Cleavable linker-based ADCs are projected to capture major market share within both the ADC drug market and the contract manufacturing segment due to their ability to release cytotoxins within tumor cells.
3. Oncology Indication Mix and Target Expansion
Breast and blood cancers are dominant application areas for ADCs. The breast cancer segment, in particular, has commanded a large share of the market, driven by HER2-targeted therapies such as Kadcyla and Enhertu. Blood cancer and other solid tumor indications are increasingly being explored in new ADC approvals.
4. Regional Leadership and Rapid Growth in Asia‐Pacific
North America holds the largest share of the ADC market, accounting for approximately 50% of revenue, due to its mature oncology infrastructure and strong R&D pipelines. Meanwhile, Asia‐Pacific is the fastest-growing region, reflecting rising healthcare investments and expanding access to advanced therapeutics across the region.
Market Segmentation
By Product
Adcetris (brentuximab vedotin)
Kadcyla (trastuzumab emtansine)
Padcev (enfortumab vedotin)
Polivy (polatuzumab vedotin)
Enhertu (trastuzumab deruxtecan)
Trodelvy (sacituzumab govitecan)
Elahere (mirvetuximab soravtansine)
Other Approved ADCs
By Linker Chemistry
Cleavable Linkers
Non-cleavable Linkers
Site-specific / Next-Gen Conjugation Technologies
By Target Antigen
HER2
CD30
TROP2
CD22
Others
By Application (Indication)
Breast Cancer
Blood Cancers (Lymphoma, Leukaemia)
Urothelial Cancer
Lung Cancer
Gynaecologic Cancers (Endometrium)
Other Solid Tumours
By End User
Hospitals
Specialty Cancer Centres
Biopharma & Contract Research Organisations
Others
By Region:
North America
Asia‐Pacific
Europe
South America
Middle East & Africa
Explore Our Full Library of Healthcare Industry Research Reports
https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr
Key Players
F. Hoffmann-La Roche Ltd
Pfizer Inc. (Seagen Inc.)
AstraZeneca plc
Gilead Sciences Inc.
Takeda Pharmaceutical Co. Ltd
For More information visit: https://www.mordorintelligence.com/industry-reports/antibody-drug-conjugates-market/companies?utm_source=openpr
Conclusion
The antibody‐drug conjugates market is growth is driven by expanding ADC adoption across cancer indications, strong performance of leading drugs like Kadcyla and Enhertu, rising outsourcing to contract manufacturers, and evolving linker and targeting technologies enhancing safety and efficacy.
North America remains the dominant region, supported by major R&D activity and regulatory infrastructure, while Asia‐Pacific offers high growth potential as access to advanced therapies expands. Leading players with established ADC portfolios and development pipelines-coupled with enhanced manufacturing capacity and regulatory momentum-stand to capture significant value.
Industry Related Reports
Antibody Drug Conjugates Contract Manufacturing Market: The Market is Segmented by Linker (Cleavable Linker and Non-Cleavable Linker), Application (Myeloma, Lymphoma, Breast Cancer, and Other Applications), Phase (Clinical and Commercial), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
Get More Insights: https://www.mordorintelligence.com/industry-reports/antibody-drug-conjugates-contract-manufacturing-market?utm_source=openpr
Bioconjugation Market: The Bioconjugation Market report segments the industry into By Products (Instruments, Reagents and Consumables), By Technique (Chemical Conjugation, Click Chemistry, and more.), By Biomolecules (Antibodies, Oligonucleotides, and more.), By Application (Therapeutics, Diagnostics, and more.), By End-User (Academic & Research Institutes, CROs & CMOs, and more.), and Geography (North America, Europe, and more.).
Get More Insights: https://www.mordorintelligence.com/industry-reports/bioconjugation-market?utm_source=openpr
Cancer Monoclonal Antibodies Market : The Cancer Monoclonal Antibodies Market Segments the Industry Into by Source of Antibody (Murine, Chimeric, and More), Monoclonal Antibody Therapy (Bevacizumab, Trastuzumab, and More), Cancer Application (Breast Cancer, and More), Distribution Channel (Hospital Pharmacies, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).
Get More Insights: https://www.mordorintelligence.com/industry-reports/cancer-monoclonal-antibodies-market?utm_source=openpr
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody‐Drug Conjugates Market to Reach USD 57.02 Billion by 2030, Fueled by Rapid Oncology Advances and Contract Manufacturing Expansion here
News-ID: 4121544 • Views: …
More Releases from Mordor Intelligence
Smart Meters Market to Reach 257.62 Million Units by 2030, Driven by Increasing …
Mordor Intelligence has published a new report on the Smart Meters (AMI) Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Understanding the Smart Meters (AMI) Market Overview
The smart meters (AMI) market size in terms of shipment volume is expected to grow from 173.29 million units in 2025 to 257.62 million units by 2030, advancing at an 8.25% CAGR. This steady growth reflects increasing regulatory…
Plastics Injection Molding Market to Reach 193.76 Million Tons by 2030, Driven b …
A recently released report by Mordor Intelligence analyzes the "Plastics Injection Molding Market," highlighting key developments, market growth, and expected trends through 2030.
Plastics Injection Molding Market Outlook
The global plastics injection molding market is on track to grow steadily, with volume expected to increase from 157.13 million tons in 2025 to 193.76 million tons by 2030Mordor Intelligence.
As industries continue to seek cost-effective and high-volume production methods, injection molding offers a reliable…
Sauna And Spa Market Expected to Reach USD 186.86 Billion by 2030, Driven by Wel …
Mordor Intelligence has published a new report on the Sauna and Spa Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Sauna And Spa Market Outlook
According to Mordor Intelligence, the Sauna And Spa Market size reached USD 148.79 billion in 2025 and is projected to climb to USD 186.86 billion by 2030, reflecting a 4.66% CAGR over the forecast period. This growth is driven by increasing…
Freighter Aircraft Market Driven by Rising E-commerce Logistics and Global Trade …
Introduction
According to a recent report by Mordor Intelligence, the market is expected to reach roughly USD 6.95 billion in 2025 and climb to around USD 9.19 billion by 2030 at a CAGR of 5.76%.
The freighter aircraft market is experiencing steady growth as global trade and e-commerce continue to surge. These aircraft play a critical role in enabling the rapid movement of high-value and time-sensitive goods across continents. Both purpose-built…
More Releases for ADC
ADC Market: Transforming Cancer Treatment
The global market for antibody-drug conjugates (ADCs) was valued at US$ 11.32 billion in 2023 and is expected to reach US$ 27.37 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.23% from 2024 to 2033. This growth is primarily driven by the increasing prevalence of cancer and the growing demand for safe and effective treatments.
Antibody Drug Conjugates: A Growing Force in Cancer Treatment and Market Expansion
Key…
With Knockout ADC Innovations, Creative Biolabs Took Center Stage at the 2024 Wo …
Creative Biolabs wrapped up a successful show at the 15th Annual World ADC San Diego in the beginning of November, where its third year of participation, highlighting its dedication to the advancement of antibody-drug conjugate (ADC) technology.
New York, USA - November 13, 2024 - Creative Biolabs seized the spotlight at Booth 313 by offering groundbreaking solutions across the entire ADC development spectrum, which demonstrate their unrivaled expertise and dedication to…
Showing Off Their ADC Game: Creative Biolabs Hits the 15th Annual World ADC Summ …
From November 4, Creative Biolabs will be back at the 15th Annual World ADC Summit in San Diego, marking its fourth year at the leading global gathering featuring innovative conjugates.
New York, USA - November 6, 2024 - Creative Biolabs invites all ADC enthusiasts, from new entrants to seasoned experts, to explore its comprehensive suite of ADC solutions and experience the latest in antibody-drug conjugate (ADC) innovation at Booth #313.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
"2023…
ADC Drugs For Breast Cancer Treatment
Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. At present, the main therapeutic methods include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy, etc. The development and marketing of new drugs have far-reaching significance in improving the survival of breast cancer patients and changing the pattern of breast cancer treatment.
On February 24, 2023, The NMPA approved Enhertu, an injectable drug developed jointly by…
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Succe …
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Successive Approximation ADC, Delta-sigma ADC, and Others (Pipelined/Flash ADC)), and Application (Consumer Electronics and Industrial) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Full Report : https://www.alliedmarketresearch.com/analog-to-digital-converters-market
Increasing disposable income and technological advancements supplement the analog-to-digital converters market. However, complex design of the ADC hampers this market growth. On the other hand, encouragement in digitization of work processes by government in emerging economies,…
Global Data Converters Market Report 2017 (Analog to Digital Converter, Current …
The research report titled Global Data Converters Sales Market Report 2017 market size and forecast and overview on current market trends.
This report studies sales (consumption) of Global Data Converters Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
National Semiconductor
Nippon Precision Circuits Inc
Micro Analog systems
Microchip Technology.
TelCom Semiconductor, Inc
Vishay Siliconix
Texas…
